📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model. (2015)

First Author: Thomas MR

Attributed to: The Effect of Antiplatelet Medications on Innate Immune Activation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/atvbaha.115.306528

PubMed Identifier: 26515417

Publication URI: http://europepmc.org/abstract/MED/26515417

Type: Journal Article/Review

Volume: 35

Parent Publication: Arteriosclerosis, thrombosis, and vascular biology

Issue: 12

ISSN: 1079-5642